Cantel Medical (CMD) Reports In-Line Q3 EPS, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2018
May 31, 2018 8:00 AM EDTLITTLE FALLS, N.J., May 31, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2018.
Jørgen B. Hansen, President and Chief Executive Officer, stated, "We are pleased to report record sales and strong earnings performance this quarter. Our 13.1% reported sales increase was driven by organic growth of 7.6%, the impact from acquisitions of 4.0%, and a favorable impact from foreign currency of 1.5%. We continue to perform well internationally where sales were up 25.6% overall, and our US business had a strong quarter with 9.1% growth."
Financial... More



